Using transgenic mouse models of MYC-induced T cell acute lymphoblastic lymphoma and pro-B cell leukemia, Kavya Rakhra et al. described how CD4+T cells home to the tumor and are sufficient to induce sustained tumor regression upon MYC inactivation [104]. This evidence concerns the gene MYC and neoplasm.